Aquestive Therapeutics
AQST
AQST
37 hedge funds and large institutions have $13.6M invested in Aquestive Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
37
Holding in Top 10
1
Calls
$52K
Puts
$1K
Top Buyers
| 1 | +$90.1K | |
| 2 | +$57K | |
| 3 | +$19.5K | |
| 4 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$4.51K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.71K |
Top Sellers
| 1 | -$395K | |
| 2 | -$390K | |
| 3 | -$32K | |
| 4 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$30K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$29.9K |